Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Fish and Richardson
Federal Trade Commission
Deloitte
Colorcon
Mallinckrodt
Chubb
Daiichi Sankyo
Harvard Business School

Generated: May 22, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR HYDROCHLOROTHIAZIDE; TRIAMTERENE

« Back to Dashboard

Clinical Trials for hydrochlorothiazide; triamterene

Trial ID Title Status Sponsor Phase Summary
NCT00000525 Diuretics, Hypertension, and Arrhythmias Clinical Trial Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 To determine whether hypertensive patients with ECG abnormalities and receiving hydrochlorothiazide diuretics were at increased risk of sudden death.
NCT00000525 Diuretics, Hypertension, and Arrhythmias Clinical Trial Completed University of California, San Francisco Phase 3 To determine whether hypertensive patients with ECG abnormalities and receiving hydrochlorothiazide diuretics were at increased risk of sudden death.
NCT00005520 Genetic Epidemiology of Responses to Antihypertensives Completed National Heart, Lung, and Blood Institute (NHLBI) N/A To determine whether measured variation in genes coding for components of vasoconstriction and volume regulating systems predict interindividual differences in blood pressure response to therapy with a thiazide diuretic, hydrochlorothiazide, or an angiotensin II receptor blocker, candesartan, in hypertensive African-Americans (N=300 treated with each drug) and in hypertensive European Americans (N=300 treated with each drug).
NCT00005520 Genetic Epidemiology of Responses to Antihypertensives Completed Mayo Clinic N/A To determine whether measured variation in genes coding for components of vasoconstriction and volume regulating systems predict interindividual differences in blood pressure response to therapy with a thiazide diuretic, hydrochlorothiazide, or an angiotensin II receptor blocker, candesartan, in hypertensive African-Americans (N=300 treated with each drug) and in hypertensive European Americans (N=300 treated with each drug).
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Clinical Trial Conditions for hydrochlorothiazide; triamterene

Condition Name

Condition Name for hydrochlorothiazide; triamterene
Intervention Trials
Hypertension 193
Healthy 34
Essential Hypertension 28
Type 2 Diabetes Mellitus 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for hydrochlorothiazide; triamterene
Intervention Trials
Hypertension 198
Diabetes Mellitus 15
Diabetes Mellitus, Type 2 12
Cardiovascular Diseases 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for hydrochlorothiazide; triamterene

Trials by Country

Trials by Country for hydrochlorothiazide; triamterene
Location Trials
United States 613
Germany 56
Japan 40
Canada 39
Netherlands 22
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for hydrochlorothiazide; triamterene
Location Trials
New Jersey 30
Texas 29
Florida 27
California 26
North Carolina 22
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for hydrochlorothiazide; triamterene

Clinical Trial Phase

Clinical Trial Phase for hydrochlorothiazide; triamterene
Clinical Trial Phase Trials
Phase 4 107
Phase 3 93
Phase 2/Phase 3 2
[disabled in preview] 19
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for hydrochlorothiazide; triamterene
Clinical Trial Phase Trials
Completed 249
Recruiting 21
Terminated 15
[disabled in preview] 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for hydrochlorothiazide; triamterene

Sponsor Name

Sponsor Name for hydrochlorothiazide; triamterene
Sponsor Trials
Novartis 48
Boehringer Ingelheim 36
Merck Sharp & Dohme Corp. 16
[disabled in preview] 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for hydrochlorothiazide; triamterene
Sponsor Trials
Industry 241
Other 156
NIH 9
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Deloitte
Colorcon
Fish and Richardson
Julphar
US Army
Johnson and Johnson
Cipla
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.